1/22
Practice flashcards covering the preparation, storage, and clinical use of various blood components as discussed in the lecture.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Closed System
A sterile blood collection set including the primary bag, attached satellite bags, and tubing.
Dextrose
An anticoagulant-preservative ingredient that supports ATP generation by the glycolytic pathway.
Adenine
An anticoagulant-preservative ingredient that acts as a substrate for RBC ATP synthesis.
Citrate
An anticoagulant-preservative ingredient that prevents coagulation by chelating calcium.
Sodium Biphosphate
An anticoagulant-preservative ingredient that acts as a buffer to prevent an excessive drop in pH.
Storage Lesion
Biochemical changes that occur when blood is stored at 1−6∘C, affecting RBC viability and function.
Acceptable Shelf Life (RBC)
A standard where 75% of RBCs remain in the recipient's circulation 24 hours after transfusion with less than 1% hemolysis.
Light Spin
The initial centrifugation step where whole blood is spun to separate platelet-rich plasma (PRP) from red blood cells.
Heavy Spin
The centrifugation step used to separate platelets from plasma.
Leukocyte Reduced RBCs
Red blood cells filtered to contain less than 5×106 WBCs to reduce adverse reactions and CMV transmission.
Apheresis RBCs
Automated collection of red cells where a final component must have a hemoglobin of at least 51g and a minimum volume of 153mL.
Glycerol
A cryoprotective agent added to RBCs before freezing to prevent the formation of ice crystals.
Deglycerolized RBCs
Frozen RBCs that have been thawed and washed with saline solutions to remove toxic glycerol, resulting in a 24-hour expiration.
Washed RBCs
RBCs rinsed with normal saline to remove plasma proteins, indicated for patients with IgA deficiency to prevent anaphylactic reactions.
Irradiated RBCs
RBCs treated with gamma rays or X-rays (2500cGy dose) to prevent transfusion-associated graft-versus-host disease (TA−GVHD) by stopping T cell proliferation.
Platelet Refractory
A state where a patient is unresponsive to platelet transfusions, often indicated by a Corrected Count Increment (CCI) of less than 5000/μL.
Fresh Frozen Plasma (FFP)
Plasma separated from whole blood and frozen within 8 hours of collection, containing all coagulation factors.
PF24
Plasma frozen within 24 hours of collection, which may have reduced levels of labile coagulation factors like Factor VIII.
Cryoprecipitated Antihemophilic Factor (CRYO)
The cold precipitate formed when FFP is thawed at 1−6∘C, containing vWF, Fibrinogen, Factor VIII, Factor XIII, and Fibronectin.
Granulocytes, Apheresis
A rare component providing functional neutrophils (1.0×1010 or more per unit) to patients with an absolute neutrophil count of <0.5×103/μL.
ISBT 128
An international standard for the labeling of blood products required by AABB standards since May 1, 2008.
Psoralen
A furocoumarin used in pathogen reduction technology that intercalates with DNA and uses UV light to inhibit pathogen replication.
170 micron filter
The standard filter size required for the administration of blood components.